Randomized Trial Of A Short Course Of Erlotinib 150 To 300 Mg Daily Prior To Surgery For Squamous Cell Carcinomas Of The Head And Neck (Scchn) In Current, Former, And Never Smokers: Objective Responses And Clinical Outcomes.

W. N. William Junior,R. S. Weber,J. J. Lee, J. Myers,L. E. Ginsberg, A. K. El-Naggar, E. M. Sturgis,A. L. Sabichi,M. S. Kies,E. Y. Hanna,A. C. Hessel,C. Lu,S. Y. Lai, R. Ayuste,S. M. Lippman,E. S. Kim

JOURNAL OF CLINICAL ONCOLOGY(2011)

引用 7|浏览12
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要